• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.

作者信息

Ashton John C

机构信息

Department of Pharmacology and Toxicology, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand.

出版信息

Cancer Res. 2015 Jun 1;75(11):2400. doi: 10.1158/0008-5472.CAN-14-3763.

DOI:10.1158/0008-5472.CAN-14-3763
PMID:25977339
Abstract
摘要

相似文献

1
Drug combination studies and their synergy quantification using the Chou-Talalay method--letter.使用周-塔拉莱法进行药物联合研究及其协同作用量化——信函
Cancer Res. 2015 Jun 1;75(11):2400. doi: 10.1158/0008-5472.CAN-14-3763.
2
Drug combination studies and their synergy quantification using the Chou-Talalay method.药物联合研究及其协同作用的定量分析——Chou-Talalay 法
Cancer Res. 2010 Jan 15;70(2):440-6. doi: 10.1158/0008-5472.CAN-09-1947. Epub 2010 Jan 12.
3
An improved model for the analysis of combined antimicrobials: a replacement for the Chou-Talalay combination index method.一种改进的联合抗菌药物分析模型：替代 Chou-Talalay 联合指数法。
J Appl Microbiol. 2018 Jan;124(1):97-107. doi: 10.1111/jam.13623. Epub 2017 Dec 7.
4
Performance and sample size requirements of Bayesian methods for binary outcomes in fixed-dose combination drug studies.固定剂量复方药物研究中二元结局的贝叶斯方法的性能与样本量要求
J Biopharm Stat. 2009;19(1):120-32. doi: 10.1080/10543400802527916.
5
Principles of combination chemotherapy.联合化疗的原则
Am J Pharm Sci Support Public Health. 1970 May-Jun;142(3):116-26.
6
[Synergistic apoptotic effect of the combination of diosgenin and TRAIL on non-small-cell lung cancer cell line A549 evaluated with the Chou-Talalay method].[采用Chou-Talalay法评估薯蓣皂苷元与TRAIL联合应用对非小细胞肺癌细胞系A549的协同凋亡作用]
Yao Xue Xue Bao. 2013 Jan;48(1):45-51.
7
[Interactions between psychotropic and other drugs (author's transl)].精神药物与其他药物之间的相互作用（作者译）
Nervenarzt. 1979 Aug;50(8):485-90.
8
Drug synergy scoring using minimal dose response matrices.使用最小剂量反应矩阵进行药物协同评分。
BMC Res Notes. 2021 Jan 19;14(1):27. doi: 10.1186/s13104-021-05445-7.
9
Two-stage model-free tests of synergy in drug combinations.药物组合中协同作用的两阶段无模型测试。
J Biopharm Stat. 2012;22(1):54-71. doi: 10.1080/10543406.2010.504314.
10
Rational approach to the clinical protocol design for drug combinations: a review.药物联合临床方案设计的合理方法：综述
Acta Paediatr Taiwan. 2000 Nov-Dec;41(6):294-302.

引用本文的文献

1
Amino acid transporter LAT1 (SLC7A5) promotes metabolic rewiring in TNBC progression through the L-Trp/QPRT/NAD pathway.氨基酸转运体LAT1（SLC7A5）通过L-色氨酸/QPRT/烟酰胺腺嘌呤二核苷酸途径促进三阴性乳腺癌进展中的代谢重塑。
J Exp Clin Cancer Res. 2025 Jul 3;44(1):190. doi: 10.1186/s13046-025-03446-z.
2
Targeting CD16A on NK cells and GPC3 in hepatocellular carcinoma: development and functional validation of a therapeutic bispecific antibody.靶向自然杀伤细胞上的CD16A和肝细胞癌中的GPC3：一种治疗性双特异性抗体的研发与功能验证
Front Immunol. 2025 Jun 12;16:1599764. doi: 10.3389/fimmu.2025.1599764. eCollection 2025.
3
Disulfiram potentiates cisplatin-induced apoptosis in small cell lung cancer via the inhibition of cystathionine β-synthase and HS.
双硫仑通过抑制胱硫醚β-合酶和半胱氨酸合成酶增强顺铂诱导的小细胞肺癌细胞凋亡。
Am J Cancer Res. 2025 Apr 15;15(4):1647-1661. doi: 10.62347/QJHB2816. eCollection 2025.
4
Napabucasin targets resistant triple negative breast cancer through suppressing STAT3 and mitochondrial function.那帕博西尼通过抑制信号转导和转录激活因子3（STAT3）及线粒体功能来靶向耐药三阴性乳腺癌。
Cancer Chemother Pharmacol. 2025 Apr 2;95(1):51. doi: 10.1007/s00280-025-04770-z.
5
Avenanthramide A potentiates Bim-mediated antineoplastic properties of 5-fluorouracil targeting KDM4C//GSK-3 negative feedback loop in colorectal cancer.阿魏酸酰胺A增强5-氟尿嘧啶靶向结直肠癌中KDM4C//GSK-3负反馈环的Bim介导的抗肿瘤特性。
Acta Pharm Sin B. 2024 Dec;14(12):5321-5340. doi: 10.1016/j.apsb.2024.07.018. Epub 2024 Jul 25.
6
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma.整合多组学研究表明，多纳非尼联合脂肪酸去饱和酶2（FADS2）抑制在肝细胞癌中具有增强的抗肿瘤疗效。
Transl Oncol. 2025 Jan;51:102142. doi: 10.1016/j.tranon.2024.102142. Epub 2024 Nov 17.
7
The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer.DPYD 基因的作用和 DPYD 抑制剂叶黄素联合 5-FU 在胰腺癌中的作用。
Cancer Med. 2024 Aug;13(16):e70124. doi: 10.1002/cam4.70124.
8
Evaluation of Anticancer Efficacy of D-α-Tocopheryl Polyethylene-Glycol Succinate and Soluplus Mixed Micelles Loaded with Olaparib and Rapamycin Against Ovarian Cancer.负载奥拉帕尼和雷帕霉素的琥珀酸聚乙二醇 -D-α-生育酚和Soluplus混合胶束对卵巢癌的抗癌疗效评估
Int J Nanomedicine. 2024 Aug 2;19:7871-7893. doi: 10.2147/IJN.S468935. eCollection 2024.
9
Pharmacokinetics-Pharmacodynamics Modeling for Evaluating Drug-Drug Interactions in Polypharmacy: Development and Challenges.多药治疗中药物-药物相互作用的药代动力学-药效学建模：开发与挑战。
Clin Pharmacokinet. 2024 Jul;63(7):919-944. doi: 10.1007/s40262-024-01391-2. Epub 2024 Jun 18.
10
Functional and structural basis of human parainfluenza virus type 3 neutralization with human monoclonal antibodies.人源单克隆抗体对3型人副流感病毒中和作用的功能和结构基础
Nat Microbiol. 2024 Aug;9(8):2128-2143. doi: 10.1038/s41564-024-01722-w. Epub 2024 Jun 10.